Literature DB >> 9156383

New prospects for antibacterial agents against multidrug-resistant pneumococci.

P C Appelbaum1.   

Abstract

Since the first description of penicillin-resistant pneumococci nearly 30 years ago, drug-resistance has become widespread throughout the world. This review focuses upon the in vitro susceptibility of penicillin-susceptible and -resistant pneumococci to new and existing agents.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 9156383     DOI： 10.1089/mdr.1995.1.43

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN： 1076-6294            Impact factor:   3.431


  6 in total

Review 1.  Emerging resistance to antimicrobial agents in gram-positive bacteria. Pneumococci.

Authors:  P C Appelbaum
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; N Peyrard; A Pechinot; M Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.

Authors:  P Urbásková; J Trupl; H Hupková; P C Appelbaum; M R Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

4.  Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland.

Authors:  J Wüst; E Huf; F H Kayser
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

5.  Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.

Authors:  K S Thomson; S A Chartrand; C C Sanders; S L Block
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

6.  Otitis Media: A Review, with a Focus on Alternative Treatments.

Authors:  L M T Dicks; H Knoetze; C A van Reenen
Journal:  Probiotics Antimicrob Proteins       Date:  2009-03-04       Impact factor: 5.265
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.